Christina Kay - Nov 9, 2022 Form 4 Insider Report for INTEGRATED BIOPHARMA INC (INBP)

Role
Co-Chief Executive Officer, Director
Signature
/s/ Christina Kay
Stock symbol
INBP
Transactions as of
Nov 9, 2022
Transactions value $
$0
Form type
4
Date filed
11/10/2022, 05:53 PM
Previous filing
Nov 3, 2021
Next filing
Sep 21, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBP Stock Option (right to buy) Award $0 +100K $0.00 100K Nov 9, 2022 Common Stock 100K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Exercise Price of the Stock Option will be the closing prices of the Issuer's Common Stock on the fifth trading day after the filing of the Issuer's Quarterly Report on Form 10-Q for the period ended September 30, 2022, with the Securities and Exchange Commission.
F2 The option vests and becomes exercisable in three equal annual installments with the first installment vesting on November 9, 2023.